We have identified type VI collagen (Col VI) as a primary subendothelial extracellular matrix component responsible for von Willebrand factor (vWF)-dependent platelet adhesion and aggregation under high tensile strength. Intact tetrameric Col VI was the form of the collagen found to be capable of promoting vWF-mediated platelet adhesion/aggregation under this shear condition, whereas removal of the predominant portion of the terminal globules by pepsin treatment abrogated its activity. The inability of the pepsin-digested Col VI to support any platelet interaction at high flow was because of the failure of the A3(vWF) domain to bind to this form of collagen, suggesting a stringent requirement of a tridimensional conformation or of intactnes...
Fibrillar collagens, the most abundant proteins in the vertebrate body, are involved in a plethora o...
We have studied the binding of von Willebrand factor to ex-tracellular matrices of endothelial cells...
Von Willebrand's disease type I, characterized by low levels of factor VIII coagulant activity (VIII...
The molecular mechanisms of binding interaction among von Willebrand factor, subendothelium and plat...
AbstractBackground: Bleeding from a damaged blood vessel is stopped by the formation of a platelet p...
Collagen VI is abundant in the arterial subendothelium. To investigate its mechanism of interaction ...
Background: Bleeding from a damaged blood vessel is stopped by the formation of a platelet plug. The...
A parallel-plate flow chamber and epifluorescence video microscopy with digital image processing tec...
AbstractBackground: Bleeding from a damaged blood vessel is stopped by the formation of a platelet p...
Background—We studied the role of glycoprotein (GP) VI in platelet adhesion and thrombus formation o...
Von Willebrand factor (VWF), a multimeric plasma glycoprotein, mediates platelet adhesion to sites ...
Von Willebrand factor (VWF), a multimeric plasma glycoprotein, mediates platelet adhesion to sites ...
Platelets play key roles in physiology, such as the arrest of bleeding following vascular injury, an...
Von Willebrand factor (vWF) is a large multimeric protein found in plasma, intracellular stores of p...
Background It has been demonstrated that von Willebrand factor (VWF) mediated platelet-endothelium ...
Fibrillar collagens, the most abundant proteins in the vertebrate body, are involved in a plethora o...
We have studied the binding of von Willebrand factor to ex-tracellular matrices of endothelial cells...
Von Willebrand's disease type I, characterized by low levels of factor VIII coagulant activity (VIII...
The molecular mechanisms of binding interaction among von Willebrand factor, subendothelium and plat...
AbstractBackground: Bleeding from a damaged blood vessel is stopped by the formation of a platelet p...
Collagen VI is abundant in the arterial subendothelium. To investigate its mechanism of interaction ...
Background: Bleeding from a damaged blood vessel is stopped by the formation of a platelet plug. The...
A parallel-plate flow chamber and epifluorescence video microscopy with digital image processing tec...
AbstractBackground: Bleeding from a damaged blood vessel is stopped by the formation of a platelet p...
Background—We studied the role of glycoprotein (GP) VI in platelet adhesion and thrombus formation o...
Von Willebrand factor (VWF), a multimeric plasma glycoprotein, mediates platelet adhesion to sites ...
Von Willebrand factor (VWF), a multimeric plasma glycoprotein, mediates platelet adhesion to sites ...
Platelets play key roles in physiology, such as the arrest of bleeding following vascular injury, an...
Von Willebrand factor (vWF) is a large multimeric protein found in plasma, intracellular stores of p...
Background It has been demonstrated that von Willebrand factor (VWF) mediated platelet-endothelium ...
Fibrillar collagens, the most abundant proteins in the vertebrate body, are involved in a plethora o...
We have studied the binding of von Willebrand factor to ex-tracellular matrices of endothelial cells...
Von Willebrand's disease type I, characterized by low levels of factor VIII coagulant activity (VIII...